Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. [PDF]
Honndorf S +7 more
europepmc +1 more source
Advances in Clostridial Neurotoxins: Passage of the Intestinal Barrier and Targeting of Specific Neuronal Cells. [PDF]
Popoff MR.
europepmc +1 more source
Presynaptic Terminal Proteins and Nicotinic Receptors Are Depleted from Mouse Parasympathetic Ganglionic Junctions Paralysed with Botulinum Neurotoxin Type A. [PDF]
Al-Sabi A, Lawrence GW.
europepmc +1 more source
Botulinum Toxin for Chronic Migraine: Beyond Headache Reduction and Toward Possible Cognitive Benefits. [PDF]
Silvestrini M +5 more
europepmc +1 more source
Botulinum Neurotoxin-A Inhibits Tumor Growth in a Triple-Negative Breast Cancer Preclinical Model. [PDF]
Lopez EN +11 more
europepmc +1 more source
Good Clinical Practices for the Management of Post-Stroke Spasticity with BoNT-A: A Delphi-Based Approach from the Italian Expert Group. [PDF]
Baricich A +7 more
europepmc +1 more source
Neurophysiological Assessment of F-Wave, M-Wave, and Cutaneous Silent Period in Patients with Caput-Pattern Cervical Dystonia at Waning and Peak Response Phases of Botulinum Toxin Therapy. [PDF]
Drużdż A +5 more
europepmc +1 more source
Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE<sup>®</sup> (TrenibotE). [PDF]
Yang Y, Zhang H, Wang S, Xue Y, Yuan L.
europepmc +1 more source
RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 Cleavage. [PDF]
Batista AF +5 more
europepmc +1 more source
Marginal Orbicularis Oris Hyperactivity (MOOH): An Exploratory Case Series of Inversion-Dominant Upper Lip Dynamics Following Intraoral Botulinum Toxin Type A. [PDF]
Armenti AF.
europepmc +1 more source

